Last update Oct. 15, 2016
Compatible
We do not have alternatives for C16H16N3NaO7S2 since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
C16H16N3NaO7S2 is Cefoxitin Sodium in Molecular formula.
Is written in other languages:C16H16N3NaO7S2 belongs to this group or family:
Main tradenames from several countries containing C16H16N3NaO7S2 in its composition:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Second-generation cephalosporin for injection or parenteral administration.
Like most cephalosporins for which data are available, excretion occurs in breast milk in very small amount and it is clinically insignificant (references from Geddes 1977 to Zhang 1997).
Cephalosporins are widely used in the Pediatric practice with a good tolerance, even in the neonatal period, so it is very unlikely that in small amounts through milk would be a cause of problems in the infant.
Be aware of the possibility of false negative results of cultures in febrile infants whose mothers are taking antibiotics as well as the possibility of gastroenteritis (Ito 1993) by altering the intestinal flora.
American Academy of Pediatrics: Maternal Medication Usually Compatible With Breastfeeding